English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

lia ssi Yet, it is a difficult anticoagulant to manage, largely be-cause of a narrow therapeutic window therefore requiring 2 days after initiating treatment, with the attendant risks able so far mostly pertained to patients initially managed in a conservative fashion and there has been a clear LMWH in the context of PCI. Yet, the actual evidence antagonist to effectively reverse the action of LMWH was viewed with concern. 0195-668X/ $- see front matter c 2004 Published by Elsevier Ltd on behalf of The European Society of Cardiology. doi:10.1016/j.ehj.2004.07.028 P.G. Steg has been a consultant, a speaker and has received research grants from Aventis Pharma.  doi:10.1016/j.ehj.2004.06.028

Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefit